Related Experiment Video
Updated: Oct 2, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Monitoring of Testosterone Replacement Therapy to Optimize the Benefit-to-Risk Ratio
1Reproductive Endocrine Unit, BHX5, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.
Abstract:
For hypogonadal men treated with testosterone, the goal is to ensure that benefits are optimized, risks are minimized, and any adverse effects are identified early and managed appropriately. This can best be achieved by careful patient selection, excluding men with contraindications and addressing any modifiable risk factors in those at increased risk. A standardized plan should be used for monitoring that includes evaluation of symptoms, side effects, adherence, and measurement of testosterone and hematocrit. Shared decision making should be used to determine whether to screen for prostate cancer and informed by age, baseline cancer risk, and patient preference.
Insights
Optimizing testosterone replacement therapy for hypogonadal men involves careful patient selection and monitoring. This approach minimizes risks and ensures benefits are maximized while managing adverse effects effectively.
Area of Science:
- Endocrinology
- Men's Health
- Pharmacology
Background:
- Hypogonadism requires testosterone replacement therapy (TRT) to manage symptoms and health risks.
- Effective TRT necessitates balancing therapeutic benefits against potential adverse effects.
- Optimizing TRT outcomes requires a structured approach to patient management.
Purpose of the Study:
- To outline a strategy for optimizing testosterone therapy in hypogonadal men.
- To detail methods for minimizing risks and managing adverse effects of TRT.
- To guide the monitoring and shared decision-making processes in TRT.
Main Methods:
- Careful patient selection, excluding contraindications.
- Addressing modifiable risk factors in at-risk individuals.
- Standardized monitoring of symptoms, side effects, adherence, testosterone levels, and hematocrit.
- Shared decision-making for prostate cancer screening based on individual risk factors and preferences.
Main Results:
- A systematic approach to patient selection and risk factor management is crucial for TRT.
- Standardized monitoring protocols aid in early detection and management of adverse effects.
- Shared decision-making empowers patients in managing their TRT and related health screenings.
Conclusions:
- Optimized testosterone therapy requires individualized patient selection and ongoing monitoring.
- Proactive management of risks and side effects enhances TRT safety and efficacy.
- Shared decision-making is essential for personalized TRT and prostate cancer screening strategies.
Related Concept Videos
Testosterone: Functions and Regulation
Therapeutic Index
Hormonal Regulation
Drug Therapy
Antianxiety Medications
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Kidney Transplant III: Nursing Management

